nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—prostate cancer—testicular cancer	0.52	1	CtDrD
Estradiol—SLCO1A2—Chlorambucil—testicular cancer	0.0336	0.0997	CbGbCtD
Estradiol—ABCC10—Etoposide—testicular cancer	0.0264	0.0784	CbGbCtD
Estradiol—ABCC10—Doxorubicin—testicular cancer	0.018	0.0535	CbGbCtD
Estradiol—ABCC10—Methotrexate—testicular cancer	0.0174	0.0518	CbGbCtD
Estradiol—SLCO1C1—Methotrexate—testicular cancer	0.0174	0.0518	CbGbCtD
Estradiol—AOX1—Methotrexate—testicular cancer	0.0165	0.049	CbGbCtD
Estradiol—UGT1A1—Etoposide—testicular cancer	0.0124	0.0368	CbGbCtD
Estradiol—ABCG2—Dactinomycin—testicular cancer	0.0121	0.0359	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0105	0.0313	CbGbCtD
Estradiol—CYP3A7—Ifosfamide—testicular cancer	0.0105	0.0313	CbGbCtD
Estradiol—SLC22A2—Vinblastine—testicular cancer	0.0103	0.0305	CbGbCtD
Estradiol—CYP1B1—Doxorubicin—testicular cancer	0.00979	0.0291	CbGbCtD
Estradiol—SLCO1B3—Methotrexate—testicular cancer	0.00974	0.0289	CbGbCtD
Estradiol—SLC22A2—Cisplatin—testicular cancer	0.00941	0.0279	CbGbCtD
Estradiol—SLC22A11—Methotrexate—testicular cancer	0.009	0.0267	CbGbCtD
Estradiol—ABCG2—Carboplatin—testicular cancer	0.00813	0.0241	CbGbCtD
Estradiol—CYP3A5—Ifosfamide—testicular cancer	0.00791	0.0235	CbGbCtD
Estradiol—CYP2C8—Ifosfamide—testicular cancer	0.0076	0.0226	CbGbCtD
Estradiol—ABCG2—Cisplatin—testicular cancer	0.00694	0.0206	CbGbCtD
Estradiol—ABCG2—Etoposide—testicular cancer	0.00682	0.0203	CbGbCtD
Estradiol—CYP2C19—Ifosfamide—testicular cancer	0.00638	0.0189	CbGbCtD
Estradiol—SLCO1A2—Methotrexate—testicular cancer	0.00601	0.0179	CbGbCtD
Estradiol—SLCO1B1—Methotrexate—testicular cancer	0.00567	0.0168	CbGbCtD
Estradiol—CYP2C9—Ifosfamide—testicular cancer	0.0053	0.0157	CbGbCtD
Estradiol—SLC22A8—Methotrexate—testicular cancer	0.00524	0.0155	CbGbCtD
Estradiol—ABCG2—Doxorubicin—testicular cancer	0.00465	0.0138	CbGbCtD
Estradiol—ABCG2—Methotrexate—testicular cancer	0.00451	0.0134	CbGbCtD
Estradiol—ESR2—seminiferous tubule of testis—testicular cancer	0.0044	0.0981	CbGeAlD
Estradiol—ABCB1—Dactinomycin—testicular cancer	0.00436	0.0129	CbGbCtD
Estradiol—SHBG—seminiferous tubule of testis—testicular cancer	0.00428	0.0954	CbGeAlD
Estradiol—AR—scrotum—testicular cancer	0.00395	0.088	CbGeAlD
Estradiol—CYP3A5—Etoposide—testicular cancer	0.00378	0.0112	CbGbCtD
Estradiol—CYP2C8—Etoposide—testicular cancer	0.00363	0.0108	CbGbCtD
Estradiol—ALB—Methotrexate—testicular cancer	0.00311	0.00923	CbGbCtD
Estradiol—CYP3A4—Ifosfamide—testicular cancer	0.00308	0.00916	CbGbCtD
Estradiol—AR—seminiferous tubule of testis—testicular cancer	0.00307	0.0685	CbGeAlD
Estradiol—CYP1A2—Etoposide—testicular cancer	0.00281	0.00835	CbGbCtD
Estradiol—ABCB1—Vinblastine—testicular cancer	0.00273	0.00811	CbGbCtD
Estradiol—CYP2C9—Cisplatin—testicular cancer	0.00258	0.00766	CbGbCtD
Estradiol—ABCB1—Cisplatin—testicular cancer	0.0025	0.00743	CbGbCtD
Estradiol—ABCB1—Etoposide—testicular cancer	0.00246	0.0073	CbGbCtD
Estradiol—ESR2—Ovarian Infertility Genes—DAZL—testicular cancer	0.00245	0.152	CbGpPWpGaD
Estradiol—SHBG—semen—testicular cancer	0.00237	0.0527	CbGeAlD
Estradiol—FABP2—embryo—testicular cancer	0.00217	0.0484	CbGeAlD
Estradiol—ESRRB—gonad—testicular cancer	0.00194	0.0433	CbGeAlD
Estradiol—AR—semen—testicular cancer	0.0017	0.0379	CbGeAlD
Estradiol—ABCB1—Doxorubicin—testicular cancer	0.00168	0.00498	CbGbCtD
Estradiol—CYP3A4—Vinblastine—testicular cancer	0.00164	0.00486	CbGbCtD
Estradiol—ABCB1—Methotrexate—testicular cancer	0.00163	0.00483	CbGbCtD
Estradiol—CYP3A4—Etoposide—testicular cancer	0.00147	0.00438	CbGbCtD
Estradiol—ESRRB—testis—testicular cancer	0.0014	0.0312	CbGeAlD
Estradiol—CYP3A4—Doxorubicin—testicular cancer	0.00101	0.00298	CbGbCtD
Estradiol—GPER1—testis—testicular cancer	0.000963	0.0215	CbGeAlD
Estradiol—ESRRA—Preimplantation Embryo—DNMT3L—testicular cancer	0.000952	0.059	CbGpPWpGaD
Estradiol—ESRRA—seminal vesicle—testicular cancer	0.00086	0.0192	CbGeAlD
Estradiol—FABP2—lymph node—testicular cancer	0.00077	0.0172	CbGeAlD
Estradiol—GPER1—Peptide ligand-binding receptors—INSL3—testicular cancer	0.000746	0.0463	CbGpPWpGaD
Estradiol—GPER1—lymph node—testicular cancer	0.000698	0.0156	CbGeAlD
Estradiol—SLCO4A1—seminal vesicle—testicular cancer	0.000582	0.013	CbGeAlD
Estradiol—ESRRA—female gonad—testicular cancer	0.000505	0.0113	CbGeAlD
Estradiol—GPER1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.0005	0.031	CbGpPWpGaD
Estradiol—AOX1—seminal vesicle—testicular cancer	0.000497	0.0111	CbGeAlD
Estradiol—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000487	0.0302	CbGpPWpGaD
Estradiol—ABCC10—seminal vesicle—testicular cancer	0.000483	0.0108	CbGeAlD
Estradiol—ESRRA—testis—testicular cancer	0.000448	0.00998	CbGeAlD
Estradiol—SLC22A3—embryo—testicular cancer	0.00044	0.00982	CbGeAlD
Estradiol—SLC22A3—seminal vesicle—testicular cancer	0.000413	0.00922	CbGeAlD
Estradiol—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000412	0.0256	CbGpPWpGaD
Estradiol—SLCO4A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000402	0.025	CbGpPWpGaD
Estradiol—GPER1—GPCR ligand binding—INSL3—testicular cancer	0.000381	0.0236	CbGpPWpGaD
Estradiol—SLCO1C1—testis—testicular cancer	0.000378	0.00843	CbGeAlD
Estradiol—ESR1—embryo—testicular cancer	0.000376	0.00839	CbGeAlD
Estradiol—ESR2—gonad—testicular cancer	0.000373	0.00831	CbGeAlD
Estradiol—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000372	0.0231	CbGpPWpGaD
Estradiol—SHBG—gonad—testicular cancer	0.000362	0.00808	CbGeAlD
Estradiol—AR—seminal vesicle—testicular cancer	0.00036	0.00803	CbGeAlD
Estradiol—AOX1—gonad—testicular cancer	0.000359	0.008	CbGeAlD
Estradiol—ABCC10—gonad—testicular cancer	0.000349	0.00779	CbGeAlD
Estradiol—SLCO1C1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000337	0.0209	CbGpPWpGaD
Estradiol—ESRRA—lymph node—testicular cancer	0.000324	0.00724	CbGeAlD
Estradiol—SLCO4A1—testis—testicular cancer	0.000303	0.00676	CbGeAlD
Estradiol—ESR2—female gonad—testicular cancer	0.000303	0.00675	CbGeAlD
Estradiol—SLC22A3—gonad—testicular cancer	0.000299	0.00666	CbGeAlD
Estradiol—SHBG—female gonad—testicular cancer	0.000294	0.00657	CbGeAlD
Estradiol—AOX1—female gonad—testicular cancer	0.000292	0.0065	CbGeAlD
Estradiol—ABCC10—female gonad—testicular cancer	0.000284	0.00633	CbGeAlD
Estradiol—ABCG2—seminal vesicle—testicular cancer	0.000283	0.00631	CbGeAlD
Estradiol—CYP1B1—gonad—testicular cancer	0.000275	0.00612	CbGeAlD
Estradiol—SLCO1C1—lymph node—testicular cancer	0.000274	0.00611	CbGeAlD
Estradiol—ESR2—testis—testicular cancer	0.000269	0.00599	CbGeAlD
Estradiol—SLCO2B1—female gonad—testicular cancer	0.000266	0.00593	CbGeAlD
Estradiol—SHBG—testis—testicular cancer	0.000261	0.00582	CbGeAlD
Estradiol—AR—gonad—testicular cancer	0.00026	0.0058	CbGeAlD
Estradiol—AOX1—testis—testicular cancer	0.000259	0.00577	CbGeAlD
Estradiol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000259	0.016	CbGpPWpGaD
Estradiol—ESR1—gonad—testicular cancer	0.000255	0.00569	CbGeAlD
Estradiol—ABCC10—testis—testicular cancer	0.000252	0.00561	CbGeAlD
Estradiol—SLCO2B1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000244	0.0152	CbGpPWpGaD
Estradiol—SLC22A3—female gonad—testicular cancer	0.000243	0.00541	CbGeAlD
Estradiol—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000241	0.015	CbGpPWpGaD
Estradiol—SLCO2B1—testis—testicular cancer	0.000236	0.00526	CbGeAlD
Estradiol—ABCC10—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000226	0.014	CbGpPWpGaD
Estradiol—CYP1B1—female gonad—testicular cancer	0.000223	0.00498	CbGeAlD
Estradiol—UGT1A1—NRF2 pathway—SLC2A6—testicular cancer	0.000222	0.0138	CbGpPWpGaD
Estradiol—SLC22A11—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000221	0.0137	CbGpPWpGaD
Estradiol—SLCO4A1—lymph node—testicular cancer	0.00022	0.0049	CbGeAlD
Estradiol—SLCO1A2—testis—testicular cancer	0.000217	0.00484	CbGeAlD
Estradiol—ALB—testis—testicular cancer	0.000216	0.00481	CbGeAlD
Estradiol—SLC22A3—testis—testicular cancer	0.000215	0.0048	CbGeAlD
Estradiol—GPER1—GPCR downstream signaling—INSL3—testicular cancer	0.000215	0.0134	CbGpPWpGaD
Estradiol—AR—female gonad—testicular cancer	0.000211	0.00471	CbGeAlD
Estradiol—ESR1—female gonad—testicular cancer	0.000207	0.00463	CbGeAlD
Estradiol—ESRRB—Gene Expression—DNMT3L—testicular cancer	0.000205	0.0127	CbGpPWpGaD
Estradiol—SLCO4A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000204	0.0127	CbGpPWpGaD
Estradiol—CYP1B1—testis—testicular cancer	0.000198	0.00441	CbGeAlD
Estradiol—GPER1—Signaling by GPCR—INSL3—testicular cancer	0.000195	0.0121	CbGpPWpGaD
Estradiol—ESR2—lymph node—testicular cancer	0.000195	0.00434	CbGeAlD
Estradiol—SLCO1B3—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000191	0.0118	CbGpPWpGaD
Estradiol—CYP1B1—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000189	0.0117	CbGpPWpGaD
Estradiol—AOX1—lymph node—testicular cancer	0.000187	0.00418	CbGeAlD
Estradiol—AR—testis—testicular cancer	0.000187	0.00418	CbGeAlD
Estradiol—SLC22A3—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000187	0.0116	CbGpPWpGaD
Estradiol—ESR1—testis—testicular cancer	0.000184	0.0041	CbGeAlD
Estradiol—ABCC10—lymph node—testicular cancer	0.000182	0.00407	CbGeAlD
Estradiol—CYP1B1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000177	0.011	CbGpPWpGaD
Estradiol—ESR1—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000176	0.0109	CbGpPWpGaD
Estradiol—SLCO1C1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000171	0.0106	CbGpPWpGaD
Estradiol—SLCO2B1—lymph node—testicular cancer	0.000171	0.00381	CbGeAlD
Estradiol—SLC22A8—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000169	0.0105	CbGpPWpGaD
Estradiol—ABCG2—female gonad—testicular cancer	0.000166	0.00371	CbGeAlD
Estradiol—CYP1A1—female gonad—testicular cancer	0.000158	0.00352	CbGeAlD
Estradiol—ALB—lymph node—testicular cancer	0.000156	0.00349	CbGeAlD
Estradiol—SLC22A3—lymph node—testicular cancer	0.000156	0.00348	CbGeAlD
Estradiol—ESR2—Plasma membrane estrogen receptor signaling—MMP2—testicular cancer	0.000156	0.00965	CbGpPWpGaD
Estradiol—CYP3A5—female gonad—testicular cancer	0.000154	0.00344	CbGeAlD
Estradiol—CYP2C8—testis—testicular cancer	0.000152	0.00338	CbGeAlD
Estradiol—SLCO1A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00015	0.0093	CbGpPWpGaD
Estradiol—ABCB1—embryo—testicular cancer	0.000149	0.00331	CbGeAlD
Estradiol—ABCG2—testis—testicular cancer	0.000147	0.00329	CbGeAlD
Estradiol—CYP1B1—lymph node—testicular cancer	0.000143	0.0032	CbGeAlD
Estradiol—ABCB1—seminal vesicle—testicular cancer	0.00014	0.00311	CbGeAlD
Estradiol—AR—lymph node—testicular cancer	0.000136	0.00303	CbGeAlD
Estradiol—ESR1—LKB1 signaling events—STK11—testicular cancer	0.000135	0.00838	CbGpPWpGaD
Estradiol—ESR1—lymph node—testicular cancer	0.000133	0.00297	CbGeAlD
Estradiol—SLCO1B1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000128	0.00796	CbGpPWpGaD
Estradiol—SLCO2B1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000124	0.00771	CbGpPWpGaD
Estradiol—UGT1A1—Phase II conjugation—HPGDS—testicular cancer	0.000121	0.0075	CbGpPWpGaD
Estradiol—SLC22A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000118	0.00729	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000117	0.00723	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—INSL3—testicular cancer	0.000115	0.00716	CbGpPWpGaD
Estradiol—SLC22A11—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000113	0.00698	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000112	0.00693	CbGpPWpGaD
Estradiol—SLC22A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00011	0.0068	CbGpPWpGaD
Estradiol—CYP1A1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000109	0.00677	CbGpPWpGaD
Estradiol—ABCG2—lymph node—testicular cancer	0.000107	0.00238	CbGeAlD
Estradiol—CYP1A1—lymph node—testicular cancer	0.000101	0.00226	CbGeAlD
Estradiol—ABCB1—gonad—testicular cancer	0.000101	0.00225	CbGeAlD
Estradiol—CYP2C8—Arachidonic acid metabolism—HPGDS—testicular cancer	0.0001	0.0062	CbGpPWpGaD
Estradiol—SLCO1B3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	9.7e-05	0.00602	CbGpPWpGaD
Estradiol—SLC22A3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	9.52e-05	0.00591	CbGpPWpGaD
Estradiol—CYP2C19—Arachidonic acid metabolism—HPGDS—testicular cancer	8.93e-05	0.00554	CbGpPWpGaD
Estradiol—ESRRA—Gene Expression—DNMT3L—testicular cancer	8.77e-05	0.00544	CbGpPWpGaD
Estradiol—SLC22A8—Transmembrane transport of small molecules—SLC2A6—testicular cancer	8.58e-05	0.00532	CbGpPWpGaD
Estradiol—ABCB1—female gonad—testicular cancer	8.19e-05	0.00183	CbGeAlD
Estradiol—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	8.14e-05	0.00505	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	8.12e-05	0.00504	CbGpPWpGaD
Estradiol—NR1I2—Gene Expression—DNMT3L—testicular cancer	7.93e-05	0.00492	CbGpPWpGaD
Estradiol—ESR1—Plasma membrane estrogen receptor signaling—MMP2—testicular cancer	7.85e-05	0.00487	CbGpPWpGaD
Estradiol—ESR1—FOXM1 transcription factor network—MMP2—testicular cancer	7.7e-05	0.00477	CbGpPWpGaD
Estradiol—SLCO1A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	7.62e-05	0.00473	CbGpPWpGaD
Estradiol—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	7.51e-05	0.00466	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	7.44e-05	0.00461	CbGpPWpGaD
Estradiol—ESRRA—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	7.33e-05	0.00455	CbGpPWpGaD
Estradiol—ALB—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	7.33e-05	0.00455	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	7.32e-05	0.00454	CbGpPWpGaD
Estradiol—ABCB1—testis—testicular cancer	7.27e-05	0.00162	CbGeAlD
Estradiol—ESRRB—Gene Expression—H2AFZ—testicular cancer	7.19e-05	0.00446	CbGpPWpGaD
Estradiol—UGT1A1—Biological oxidations—HPGDS—testicular cancer	7.07e-05	0.00439	CbGpPWpGaD
Estradiol—CYP1A2—Arachidonic acid metabolism—HPGDS—testicular cancer	6.96e-05	0.00432	CbGpPWpGaD
Estradiol—CYP1B1—Biological oxidations—HPGDS—testicular cancer	6.59e-05	0.00409	CbGpPWpGaD
Estradiol—SLCO1B1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	6.52e-05	0.00404	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—STK11—testicular cancer	6.42e-05	0.00398	CbGpPWpGaD
Estradiol—ABCG2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	6.03e-05	0.00374	CbGpPWpGaD
Estradiol—SLC22A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	5.97e-05	0.0037	CbGpPWpGaD
Estradiol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—testicular cancer	5.97e-05	0.0037	CbGpPWpGaD
Estradiol—CYP3A7—Biological oxidations—HPGDS—testicular cancer	5.94e-05	0.00369	CbGpPWpGaD
Estradiol—ESR1—ATF-2 transcription factor network—MMP2—testicular cancer	5.86e-05	0.00364	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	5.64e-05	0.0035	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—DNMT3L—testicular cancer	5.58e-05	0.00346	CbGpPWpGaD
Estradiol—SLC22A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	5.57e-05	0.00345	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	5.32e-05	0.0033	CbGpPWpGaD
Estradiol—ABCB1—lymph node—testicular cancer	5.27e-05	0.00117	CbGeAlD
Estradiol—ESR1—Integrated Breast Cancer Pathway—STK11—testicular cancer	4.94e-05	0.00307	CbGpPWpGaD
Estradiol—ESR1—Signaling by ERBB4—KITLG—testicular cancer	4.55e-05	0.00282	CbGpPWpGaD
Estradiol—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	4.42e-05	0.00275	CbGpPWpGaD
Estradiol—CYP3A5—Biological oxidations—HPGDS—testicular cancer	4.3e-05	0.00267	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	4.09e-05	0.00254	CbGpPWpGaD
Estradiol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	4.06e-05	0.00252	CbGpPWpGaD
Estradiol—CYP1A1—Biological oxidations—HPGDS—testicular cancer	4.06e-05	0.00252	CbGpPWpGaD
Estradiol—Infestation—Doxorubicin—testicular cancer	3.79e-05	0.000459	CcSEcCtD
Estradiol—Visual impairment—Methotrexate—testicular cancer	3.79e-05	0.000459	CcSEcCtD
Estradiol—Vomiting—Ifosfamide—testicular cancer	3.75e-05	0.000454	CcSEcCtD
Estradiol—Hypersensitivity—Cisplatin—testicular cancer	3.75e-05	0.000454	CcSEcCtD
Estradiol—ALB—Transmembrane transport of small molecules—SLC2A6—testicular cancer	3.72e-05	0.00231	CbGpPWpGaD
Estradiol—Rash—Ifosfamide—testicular cancer	3.72e-05	0.000451	CcSEcCtD
Estradiol—CYP2C8—Biological oxidations—HPGDS—testicular cancer	3.72e-05	0.00231	CbGpPWpGaD
Estradiol—Dermatitis—Ifosfamide—testicular cancer	3.72e-05	0.00045	CcSEcCtD
Estradiol—Erythema multiforme—Methotrexate—testicular cancer	3.72e-05	0.00045	CcSEcCtD
Estradiol—Neuropathy peripheral—Doxorubicin—testicular cancer	3.72e-05	0.00045	CcSEcCtD
Estradiol—Urticaria—Etoposide—testicular cancer	3.7e-05	0.000449	CcSEcCtD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.7e-05	0.0023	CbGpPWpGaD
Estradiol—Haemoglobin—Epirubicin—testicular cancer	3.7e-05	0.000448	CcSEcCtD
Estradiol—Jaundice—Doxorubicin—testicular cancer	3.7e-05	0.000448	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—H2AFZ—testicular cancer	3.7e-05	0.00229	CbGpPWpGaD
Estradiol—Rhinitis—Epirubicin—testicular cancer	3.69e-05	0.000447	CcSEcCtD
Estradiol—Body temperature increased—Etoposide—testicular cancer	3.69e-05	0.000446	CcSEcCtD
Estradiol—Abdominal pain—Etoposide—testicular cancer	3.69e-05	0.000446	CcSEcCtD
Estradiol—Conjunctivitis—Doxorubicin—testicular cancer	3.69e-05	0.000446	CcSEcCtD
Estradiol—Urinary tract infection—Doxorubicin—testicular cancer	3.69e-05	0.000446	CcSEcCtD
Estradiol—Hepatitis—Epirubicin—testicular cancer	3.68e-05	0.000445	CcSEcCtD
Estradiol—Haemorrhage—Epirubicin—testicular cancer	3.68e-05	0.000445	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—STK11—testicular cancer	3.67e-05	0.00228	CbGpPWpGaD
Estradiol—Eye disorder—Methotrexate—testicular cancer	3.67e-05	0.000445	CcSEcCtD
Estradiol—Tinnitus—Methotrexate—testicular cancer	3.67e-05	0.000444	CcSEcCtD
Estradiol—Hypoaesthesia—Epirubicin—testicular cancer	3.66e-05	0.000443	CcSEcCtD
Estradiol—AR—Gene Expression—DNMT3L—testicular cancer	3.65e-05	0.00227	CbGpPWpGaD
Estradiol—Asthenia—Cisplatin—testicular cancer	3.65e-05	0.000442	CcSEcCtD
Estradiol—Pharyngitis—Epirubicin—testicular cancer	3.65e-05	0.000442	CcSEcCtD
Estradiol—Cardiac disorder—Methotrexate—testicular cancer	3.65e-05	0.000442	CcSEcCtD
Estradiol—Urinary tract disorder—Epirubicin—testicular cancer	3.63e-05	0.00044	CcSEcCtD
Estradiol—Oedema peripheral—Epirubicin—testicular cancer	3.62e-05	0.000439	CcSEcCtD
Estradiol—Haematuria—Doxorubicin—testicular cancer	3.62e-05	0.000438	CcSEcCtD
Estradiol—Connective tissue disorder—Epirubicin—testicular cancer	3.62e-05	0.000438	CcSEcCtD
Estradiol—Urethral disorder—Epirubicin—testicular cancer	3.61e-05	0.000437	CcSEcCtD
Estradiol—Hepatobiliary disease—Doxorubicin—testicular cancer	3.59e-05	0.000434	CcSEcCtD
Estradiol—Epistaxis—Doxorubicin—testicular cancer	3.58e-05	0.000433	CcSEcCtD
Estradiol—Angiopathy—Methotrexate—testicular cancer	3.57e-05	0.000432	CcSEcCtD
Estradiol—Sinusitis—Doxorubicin—testicular cancer	3.56e-05	0.000431	CcSEcCtD
Estradiol—Immune system disorder—Methotrexate—testicular cancer	3.55e-05	0.00043	CcSEcCtD
Estradiol—Visual impairment—Epirubicin—testicular cancer	3.55e-05	0.000429	CcSEcCtD
Estradiol—Mediastinal disorder—Methotrexate—testicular cancer	3.54e-05	0.000429	CcSEcCtD
Estradiol—Chills—Methotrexate—testicular cancer	3.53e-05	0.000427	CcSEcCtD
Estradiol—Nausea—Ifosfamide—testicular cancer	3.51e-05	0.000425	CcSEcCtD
Estradiol—Diarrhoea—Cisplatin—testicular cancer	3.48e-05	0.000422	CcSEcCtD
Estradiol—Erythema multiforme—Epirubicin—testicular cancer	3.48e-05	0.000421	CcSEcCtD
Estradiol—Alopecia—Methotrexate—testicular cancer	3.47e-05	0.000421	CcSEcCtD
Estradiol—Mental disorder—Methotrexate—testicular cancer	3.44e-05	0.000417	CcSEcCtD
Estradiol—Eye disorder—Epirubicin—testicular cancer	3.44e-05	0.000416	CcSEcCtD
Estradiol—Hypersensitivity—Etoposide—testicular cancer	3.44e-05	0.000416	CcSEcCtD
Estradiol—Tinnitus—Epirubicin—testicular cancer	3.43e-05	0.000415	CcSEcCtD
Estradiol—Malnutrition—Methotrexate—testicular cancer	3.42e-05	0.000414	CcSEcCtD
Estradiol—Erythema—Methotrexate—testicular cancer	3.42e-05	0.000414	CcSEcCtD
Estradiol—Haemoglobin—Doxorubicin—testicular cancer	3.42e-05	0.000414	CcSEcCtD
Estradiol—Cardiac disorder—Epirubicin—testicular cancer	3.41e-05	0.000413	CcSEcCtD
Estradiol—Flushing—Epirubicin—testicular cancer	3.41e-05	0.000413	CcSEcCtD
Estradiol—Rhinitis—Doxorubicin—testicular cancer	3.41e-05	0.000413	CcSEcCtD
Estradiol—Hepatitis—Doxorubicin—testicular cancer	3.4e-05	0.000412	CcSEcCtD
Estradiol—Haemorrhage—Doxorubicin—testicular cancer	3.4e-05	0.000412	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—KITLG—testicular cancer	3.4e-05	0.00211	CbGpPWpGaD
Estradiol—Hypoaesthesia—Doxorubicin—testicular cancer	3.39e-05	0.00041	CcSEcCtD
Estradiol—ESR1—Signaling by ERBB4—FGFR3—testicular cancer	3.38e-05	0.0021	CbGpPWpGaD
Estradiol—Pharyngitis—Doxorubicin—testicular cancer	3.38e-05	0.000409	CcSEcCtD
Estradiol—Urinary tract disorder—Doxorubicin—testicular cancer	3.36e-05	0.000407	CcSEcCtD
Estradiol—Oedema peripheral—Doxorubicin—testicular cancer	3.35e-05	0.000406	CcSEcCtD
Estradiol—Dysgeusia—Methotrexate—testicular cancer	3.35e-05	0.000406	CcSEcCtD
Estradiol—Asthenia—Etoposide—testicular cancer	3.35e-05	0.000405	CcSEcCtD
Estradiol—Connective tissue disorder—Doxorubicin—testicular cancer	3.35e-05	0.000405	CcSEcCtD
Estradiol—Angiopathy—Epirubicin—testicular cancer	3.34e-05	0.000404	CcSEcCtD
Estradiol—Urethral disorder—Doxorubicin—testicular cancer	3.34e-05	0.000404	CcSEcCtD
Estradiol—Immune system disorder—Epirubicin—testicular cancer	3.32e-05	0.000402	CcSEcCtD
Estradiol—CYP2C19—Biological oxidations—HPGDS—testicular cancer	3.32e-05	0.00206	CbGpPWpGaD
Estradiol—Mediastinal disorder—Epirubicin—testicular cancer	3.32e-05	0.000401	CcSEcCtD
Estradiol—Back pain—Methotrexate—testicular cancer	3.31e-05	0.000401	CcSEcCtD
Estradiol—Chills—Epirubicin—testicular cancer	3.3e-05	0.0004	CcSEcCtD
Estradiol—Pruritus—Etoposide—testicular cancer	3.3e-05	0.000399	CcSEcCtD
Estradiol—Visual impairment—Doxorubicin—testicular cancer	3.28e-05	0.000397	CcSEcCtD
Estradiol—ESRRA—Metabolism—HPGDS—testicular cancer	3.27e-05	0.00203	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	3.26e-05	0.00202	CbGpPWpGaD
Estradiol—Alopecia—Epirubicin—testicular cancer	3.25e-05	0.000394	CcSEcCtD
Estradiol—Vomiting—Cisplatin—testicular cancer	3.24e-05	0.000392	CcSEcCtD
Estradiol—Mental disorder—Epirubicin—testicular cancer	3.22e-05	0.00039	CcSEcCtD
Estradiol—Erythema multiforme—Doxorubicin—testicular cancer	3.22e-05	0.00039	CcSEcCtD
Estradiol—Rash—Cisplatin—testicular cancer	3.21e-05	0.000389	CcSEcCtD
Estradiol—Dermatitis—Cisplatin—testicular cancer	3.21e-05	0.000388	CcSEcCtD
Estradiol—Erythema—Epirubicin—testicular cancer	3.2e-05	0.000388	CcSEcCtD
Estradiol—Malnutrition—Epirubicin—testicular cancer	3.2e-05	0.000388	CcSEcCtD
Estradiol—Diarrhoea—Etoposide—testicular cancer	3.19e-05	0.000386	CcSEcCtD
Estradiol—Eye disorder—Doxorubicin—testicular cancer	3.18e-05	0.000385	CcSEcCtD
Estradiol—Ill-defined disorder—Methotrexate—testicular cancer	3.18e-05	0.000384	CcSEcCtD
Estradiol—Tinnitus—Doxorubicin—testicular cancer	3.17e-05	0.000384	CcSEcCtD
Estradiol—Flushing—Doxorubicin—testicular cancer	3.16e-05	0.000383	CcSEcCtD
Estradiol—Cardiac disorder—Doxorubicin—testicular cancer	3.16e-05	0.000383	CcSEcCtD
Estradiol—Flatulence—Epirubicin—testicular cancer	3.16e-05	0.000382	CcSEcCtD
Estradiol—Tension—Epirubicin—testicular cancer	3.14e-05	0.000381	CcSEcCtD
Estradiol—Dysgeusia—Epirubicin—testicular cancer	3.14e-05	0.00038	CcSEcCtD
Estradiol—Nervousness—Epirubicin—testicular cancer	3.11e-05	0.000377	CcSEcCtD
Estradiol—ESR1—Signaling by ERBB4—KIT—testicular cancer	3.1e-05	0.00193	CbGpPWpGaD
Estradiol—Back pain—Epirubicin—testicular cancer	3.1e-05	0.000375	CcSEcCtD
Estradiol—Angiopathy—Doxorubicin—testicular cancer	3.09e-05	0.000374	CcSEcCtD
Estradiol—Malaise—Methotrexate—testicular cancer	3.09e-05	0.000374	CcSEcCtD
Estradiol—Dizziness—Etoposide—testicular cancer	3.08e-05	0.000373	CcSEcCtD
Estradiol—Muscle spasms—Epirubicin—testicular cancer	3.08e-05	0.000373	CcSEcCtD
Estradiol—Immune system disorder—Doxorubicin—testicular cancer	3.08e-05	0.000372	CcSEcCtD
Estradiol—Vertigo—Methotrexate—testicular cancer	3.08e-05	0.000372	CcSEcCtD
Estradiol—ESRRA—Gene Expression—H2AFZ—testicular cancer	3.07e-05	0.0019	CbGpPWpGaD
Estradiol—Mediastinal disorder—Doxorubicin—testicular cancer	3.07e-05	0.000371	CcSEcCtD
Estradiol—Chills—Doxorubicin—testicular cancer	3.05e-05	0.00037	CcSEcCtD
Estradiol—CYP2C9—Biological oxidations—HPGDS—testicular cancer	3.03e-05	0.00188	CbGpPWpGaD
Estradiol—Nausea—Cisplatin—testicular cancer	3.02e-05	0.000366	CcSEcCtD
Estradiol—Alopecia—Doxorubicin—testicular cancer	3.01e-05	0.000364	CcSEcCtD
Estradiol—Cough—Methotrexate—testicular cancer	2.99e-05	0.000362	CcSEcCtD
Estradiol—Mental disorder—Doxorubicin—testicular cancer	2.98e-05	0.000361	CcSEcCtD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	2.98e-05	0.00185	CbGpPWpGaD
Estradiol—Ill-defined disorder—Epirubicin—testicular cancer	2.97e-05	0.00036	CcSEcCtD
Estradiol—Vomiting—Etoposide—testicular cancer	2.97e-05	0.000359	CcSEcCtD
Estradiol—Erythema—Doxorubicin—testicular cancer	2.96e-05	0.000359	CcSEcCtD
Estradiol—Malnutrition—Doxorubicin—testicular cancer	2.96e-05	0.000359	CcSEcCtD
Estradiol—Agitation—Epirubicin—testicular cancer	2.94e-05	0.000356	CcSEcCtD
Estradiol—Rash—Etoposide—testicular cancer	2.94e-05	0.000356	CcSEcCtD
Estradiol—Dermatitis—Etoposide—testicular cancer	2.94e-05	0.000356	CcSEcCtD
Estradiol—Headache—Etoposide—testicular cancer	2.92e-05	0.000354	CcSEcCtD
Estradiol—Flatulence—Doxorubicin—testicular cancer	2.92e-05	0.000354	CcSEcCtD
Estradiol—Myalgia—Methotrexate—testicular cancer	2.91e-05	0.000353	CcSEcCtD
Estradiol—Chest pain—Methotrexate—testicular cancer	2.91e-05	0.000353	CcSEcCtD
Estradiol—Arthralgia—Methotrexate—testicular cancer	2.91e-05	0.000353	CcSEcCtD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.91e-05	0.0018	CbGpPWpGaD
Estradiol—Tension—Doxorubicin—testicular cancer	2.91e-05	0.000352	CcSEcCtD
Estradiol—Dysgeusia—Doxorubicin—testicular cancer	2.9e-05	0.000351	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	2.89e-05	0.00035	CcSEcCtD
Estradiol—Malaise—Epirubicin—testicular cancer	2.89e-05	0.00035	CcSEcCtD
Estradiol—Discomfort—Methotrexate—testicular cancer	2.88e-05	0.000349	CcSEcCtD
Estradiol—Nervousness—Doxorubicin—testicular cancer	2.88e-05	0.000348	CcSEcCtD
Estradiol—Vertigo—Epirubicin—testicular cancer	2.88e-05	0.000348	CcSEcCtD
Estradiol—Syncope—Epirubicin—testicular cancer	2.87e-05	0.000348	CcSEcCtD
Estradiol—Back pain—Doxorubicin—testicular cancer	2.87e-05	0.000347	CcSEcCtD
Estradiol—Muscle spasms—Doxorubicin—testicular cancer	2.85e-05	0.000345	CcSEcCtD
Estradiol—Palpitations—Epirubicin—testicular cancer	2.83e-05	0.000343	CcSEcCtD
Estradiol—Confusional state—Methotrexate—testicular cancer	2.82e-05	0.000341	CcSEcCtD
Estradiol—Loss of consciousness—Epirubicin—testicular cancer	2.82e-05	0.000341	CcSEcCtD
Estradiol—ESR1—Gene Expression—DNMT3L—testicular cancer	2.81e-05	0.00175	CbGpPWpGaD
Estradiol—Cough—Epirubicin—testicular cancer	2.79e-05	0.000338	CcSEcCtD
Estradiol—Anaphylactic shock—Methotrexate—testicular cancer	2.79e-05	0.000338	CcSEcCtD
Estradiol—NR1I2—Gene Expression—H2AFZ—testicular cancer	2.78e-05	0.00172	CbGpPWpGaD
Estradiol—Infection—Methotrexate—testicular cancer	2.78e-05	0.000336	CcSEcCtD
Estradiol—Nausea—Etoposide—testicular cancer	2.77e-05	0.000335	CcSEcCtD
Estradiol—Hypertension—Epirubicin—testicular cancer	2.77e-05	0.000335	CcSEcCtD
Estradiol—Ill-defined disorder—Doxorubicin—testicular cancer	2.75e-05	0.000333	CcSEcCtD
Estradiol—Nervous system disorder—Methotrexate—testicular cancer	2.74e-05	0.000332	CcSEcCtD
Estradiol—Chest pain—Epirubicin—testicular cancer	2.73e-05	0.00033	CcSEcCtD
Estradiol—Arthralgia—Epirubicin—testicular cancer	2.73e-05	0.00033	CcSEcCtD
Estradiol—Myalgia—Epirubicin—testicular cancer	2.73e-05	0.00033	CcSEcCtD
Estradiol—Agitation—Doxorubicin—testicular cancer	2.72e-05	0.00033	CcSEcCtD
Estradiol—Anxiety—Epirubicin—testicular cancer	2.72e-05	0.000329	CcSEcCtD
Estradiol—Skin disorder—Methotrexate—testicular cancer	2.71e-05	0.000328	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	2.71e-05	0.000328	CcSEcCtD
Estradiol—Hyperhidrosis—Methotrexate—testicular cancer	2.7e-05	0.000327	CcSEcCtD
Estradiol—Discomfort—Epirubicin—testicular cancer	2.69e-05	0.000326	CcSEcCtD
Estradiol—Malaise—Doxorubicin—testicular cancer	2.67e-05	0.000324	CcSEcCtD
Estradiol—Dry mouth—Epirubicin—testicular cancer	2.67e-05	0.000323	CcSEcCtD
Estradiol—Vertigo—Doxorubicin—testicular cancer	2.66e-05	0.000322	CcSEcCtD
Estradiol—Syncope—Doxorubicin—testicular cancer	2.66e-05	0.000322	CcSEcCtD
Estradiol—Confusional state—Epirubicin—testicular cancer	2.64e-05	0.000319	CcSEcCtD
Estradiol—Palpitations—Doxorubicin—testicular cancer	2.62e-05	0.000317	CcSEcCtD
Estradiol—Oedema—Epirubicin—testicular cancer	2.61e-05	0.000316	CcSEcCtD
Estradiol—Anaphylactic shock—Epirubicin—testicular cancer	2.61e-05	0.000316	CcSEcCtD
Estradiol—Loss of consciousness—Doxorubicin—testicular cancer	2.6e-05	0.000315	CcSEcCtD
Estradiol—Infection—Epirubicin—testicular cancer	2.6e-05	0.000314	CcSEcCtD
Estradiol—CYP1A2—Biological oxidations—HPGDS—testicular cancer	2.59e-05	0.00161	CbGpPWpGaD
Estradiol—Cough—Doxorubicin—testicular cancer	2.59e-05	0.000313	CcSEcCtD
Estradiol—Shock—Epirubicin—testicular cancer	2.57e-05	0.000311	CcSEcCtD
Estradiol—Nervous system disorder—Epirubicin—testicular cancer	2.56e-05	0.00031	CcSEcCtD
Estradiol—Hypertension—Doxorubicin—testicular cancer	2.56e-05	0.00031	CcSEcCtD
Estradiol—Tachycardia—Epirubicin—testicular cancer	2.55e-05	0.000309	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Methotrexate—testicular cancer	2.54e-05	0.000308	CcSEcCtD
Estradiol—Skin disorder—Epirubicin—testicular cancer	2.54e-05	0.000307	CcSEcCtD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.53e-05	0.00157	CbGpPWpGaD
Estradiol—Hyperhidrosis—Epirubicin—testicular cancer	2.53e-05	0.000306	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—FGFR3—testicular cancer	2.53e-05	0.00157	CbGpPWpGaD
Estradiol—Insomnia—Methotrexate—testicular cancer	2.53e-05	0.000306	CcSEcCtD
Estradiol—Arthralgia—Doxorubicin—testicular cancer	2.52e-05	0.000305	CcSEcCtD
Estradiol—Myalgia—Doxorubicin—testicular cancer	2.52e-05	0.000305	CcSEcCtD
Estradiol—Chest pain—Doxorubicin—testicular cancer	2.52e-05	0.000305	CcSEcCtD
Estradiol—Anxiety—Doxorubicin—testicular cancer	2.51e-05	0.000304	CcSEcCtD
Estradiol—Paraesthesia—Methotrexate—testicular cancer	2.51e-05	0.000304	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	2.51e-05	0.000303	CcSEcCtD
Estradiol—Discomfort—Doxorubicin—testicular cancer	2.49e-05	0.000302	CcSEcCtD
Estradiol—Dyspnoea—Methotrexate—testicular cancer	2.49e-05	0.000301	CcSEcCtD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.49e-05	0.00154	CbGpPWpGaD
Estradiol—Somnolence—Methotrexate—testicular cancer	2.48e-05	0.000301	CcSEcCtD
Estradiol—Dry mouth—Doxorubicin—testicular cancer	2.47e-05	0.000299	CcSEcCtD
Estradiol—Dyspepsia—Methotrexate—testicular cancer	2.46e-05	0.000298	CcSEcCtD
Estradiol—Confusional state—Doxorubicin—testicular cancer	2.44e-05	0.000295	CcSEcCtD
Estradiol—Decreased appetite—Methotrexate—testicular cancer	2.43e-05	0.000294	CcSEcCtD
Estradiol—Anaphylactic shock—Doxorubicin—testicular cancer	2.42e-05	0.000293	CcSEcCtD
Estradiol—Oedema—Doxorubicin—testicular cancer	2.42e-05	0.000293	CcSEcCtD
Estradiol—Gastrointestinal disorder—Methotrexate—testicular cancer	2.41e-05	0.000292	CcSEcCtD
Estradiol—Fatigue—Methotrexate—testicular cancer	2.41e-05	0.000292	CcSEcCtD
Estradiol—Infection—Doxorubicin—testicular cancer	2.4e-05	0.000291	CcSEcCtD
Estradiol—Pain—Methotrexate—testicular cancer	2.39e-05	0.000289	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Epirubicin—testicular cancer	2.38e-05	0.000288	CcSEcCtD
Estradiol—Shock—Doxorubicin—testicular cancer	2.38e-05	0.000288	CcSEcCtD
Estradiol—ESRRA—Metabolism—STK11—testicular cancer	2.37e-05	0.00147	CbGpPWpGaD
Estradiol—Nervous system disorder—Doxorubicin—testicular cancer	2.37e-05	0.000287	CcSEcCtD
Estradiol—Insomnia—Epirubicin—testicular cancer	2.36e-05	0.000286	CcSEcCtD
Estradiol—Tachycardia—Doxorubicin—testicular cancer	2.36e-05	0.000286	CcSEcCtD
Estradiol—Skin disorder—Doxorubicin—testicular cancer	2.35e-05	0.000284	CcSEcCtD
Estradiol—Paraesthesia—Epirubicin—testicular cancer	2.35e-05	0.000284	CcSEcCtD
Estradiol—Hyperhidrosis—Doxorubicin—testicular cancer	2.34e-05	0.000283	CcSEcCtD
Estradiol—Dyspnoea—Epirubicin—testicular cancer	2.33e-05	0.000282	CcSEcCtD
Estradiol—Somnolence—Epirubicin—testicular cancer	2.32e-05	0.000281	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—KIT—testicular cancer	2.32e-05	0.00144	CbGpPWpGaD
Estradiol—Feeling abnormal—Methotrexate—testicular cancer	2.3e-05	0.000279	CcSEcCtD
Estradiol—Dyspepsia—Epirubicin—testicular cancer	2.3e-05	0.000279	CcSEcCtD
Estradiol—Gastrointestinal pain—Methotrexate—testicular cancer	2.28e-05	0.000277	CcSEcCtD
Estradiol—Decreased appetite—Epirubicin—testicular cancer	2.27e-05	0.000275	CcSEcCtD
Estradiol—AOX1—Metabolism—HPGDS—testicular cancer	2.26e-05	0.0014	CbGpPWpGaD
Estradiol—Gastrointestinal disorder—Epirubicin—testicular cancer	2.26e-05	0.000273	CcSEcCtD
Estradiol—Fatigue—Epirubicin—testicular cancer	2.25e-05	0.000273	CcSEcCtD
Estradiol—Constipation—Epirubicin—testicular cancer	2.24e-05	0.000271	CcSEcCtD
Estradiol—Pain—Epirubicin—testicular cancer	2.24e-05	0.000271	CcSEcCtD
Estradiol—Urticaria—Methotrexate—testicular cancer	2.22e-05	0.000269	CcSEcCtD
Estradiol—Abdominal pain—Methotrexate—testicular cancer	2.21e-05	0.000267	CcSEcCtD
Estradiol—Body temperature increased—Methotrexate—testicular cancer	2.21e-05	0.000267	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	2.2e-05	0.000267	CcSEcCtD
Estradiol—Insomnia—Doxorubicin—testicular cancer	2.19e-05	0.000265	CcSEcCtD
Estradiol—Paraesthesia—Doxorubicin—testicular cancer	2.17e-05	0.000263	CcSEcCtD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	2.17e-05	0.00134	CbGpPWpGaD
Estradiol—Dyspnoea—Doxorubicin—testicular cancer	2.16e-05	0.000261	CcSEcCtD
Estradiol—Feeling abnormal—Epirubicin—testicular cancer	2.15e-05	0.000261	CcSEcCtD
Estradiol—Somnolence—Doxorubicin—testicular cancer	2.15e-05	0.00026	CcSEcCtD
Estradiol—Gastrointestinal pain—Epirubicin—testicular cancer	2.14e-05	0.000259	CcSEcCtD
Estradiol—Dyspepsia—Doxorubicin—testicular cancer	2.13e-05	0.000258	CcSEcCtD
Estradiol—Decreased appetite—Doxorubicin—testicular cancer	2.1e-05	0.000255	CcSEcCtD
Estradiol—Gastrointestinal disorder—Doxorubicin—testicular cancer	2.09e-05	0.000253	CcSEcCtD
Estradiol—Fatigue—Doxorubicin—testicular cancer	2.09e-05	0.000252	CcSEcCtD
Estradiol—Urticaria—Epirubicin—testicular cancer	2.08e-05	0.000251	CcSEcCtD
Estradiol—Constipation—Doxorubicin—testicular cancer	2.07e-05	0.00025	CcSEcCtD
Estradiol—Pain—Doxorubicin—testicular cancer	2.07e-05	0.00025	CcSEcCtD
Estradiol—Body temperature increased—Epirubicin—testicular cancer	2.07e-05	0.00025	CcSEcCtD
Estradiol—Abdominal pain—Epirubicin—testicular cancer	2.07e-05	0.00025	CcSEcCtD
Estradiol—Hypersensitivity—Methotrexate—testicular cancer	2.06e-05	0.000249	CcSEcCtD
Estradiol—Asthenia—Methotrexate—testicular cancer	2e-05	0.000243	CcSEcCtD
Estradiol—ESR1—Signaling Pathways—INSL3—testicular cancer	2e-05	0.00124	CbGpPWpGaD
Estradiol—CYP3A4—Biological oxidations—HPGDS—testicular cancer	2e-05	0.00124	CbGpPWpGaD
Estradiol—Feeling abnormal—Doxorubicin—testicular cancer	1.99e-05	0.000241	CcSEcCtD
Estradiol—Gastrointestinal pain—Doxorubicin—testicular cancer	1.98e-05	0.000239	CcSEcCtD
Estradiol—Pruritus—Methotrexate—testicular cancer	1.98e-05	0.000239	CcSEcCtD
Estradiol—AOX1—Disease—H2AFZ—testicular cancer	1.98e-05	0.00123	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—H2AFZ—testicular cancer	1.95e-05	0.00121	CbGpPWpGaD
Estradiol—Hypersensitivity—Epirubicin—testicular cancer	1.93e-05	0.000233	CcSEcCtD
Estradiol—Urticaria—Doxorubicin—testicular cancer	1.92e-05	0.000233	CcSEcCtD
Estradiol—Body temperature increased—Doxorubicin—testicular cancer	1.91e-05	0.000231	CcSEcCtD
Estradiol—Abdominal pain—Doxorubicin—testicular cancer	1.91e-05	0.000231	CcSEcCtD
Estradiol—Diarrhoea—Methotrexate—testicular cancer	1.91e-05	0.000231	CcSEcCtD
Estradiol—Asthenia—Epirubicin—testicular cancer	1.88e-05	0.000227	CcSEcCtD
Estradiol—Pruritus—Epirubicin—testicular cancer	1.85e-05	0.000224	CcSEcCtD
Estradiol—Dizziness—Methotrexate—testicular cancer	1.85e-05	0.000224	CcSEcCtD
Estradiol—AOX1—Disease—KITLG—testicular cancer	1.82e-05	0.00113	CbGpPWpGaD
Estradiol—Diarrhoea—Epirubicin—testicular cancer	1.79e-05	0.000217	CcSEcCtD
Estradiol—Hypersensitivity—Doxorubicin—testicular cancer	1.78e-05	0.000216	CcSEcCtD
Estradiol—Vomiting—Methotrexate—testicular cancer	1.78e-05	0.000215	CcSEcCtD
Estradiol—Rash—Methotrexate—testicular cancer	1.76e-05	0.000213	CcSEcCtD
Estradiol—Dermatitis—Methotrexate—testicular cancer	1.76e-05	0.000213	CcSEcCtD
Estradiol—Headache—Methotrexate—testicular cancer	1.75e-05	0.000212	CcSEcCtD
Estradiol—Asthenia—Doxorubicin—testicular cancer	1.74e-05	0.00021	CcSEcCtD
Estradiol—Dizziness—Epirubicin—testicular cancer	1.73e-05	0.000209	CcSEcCtD
Estradiol—Pruritus—Doxorubicin—testicular cancer	1.71e-05	0.000207	CcSEcCtD
Estradiol—Vomiting—Epirubicin—testicular cancer	1.66e-05	0.000201	CcSEcCtD
Estradiol—Nausea—Methotrexate—testicular cancer	1.66e-05	0.000201	CcSEcCtD
Estradiol—Diarrhoea—Doxorubicin—testicular cancer	1.65e-05	0.0002	CcSEcCtD
Estradiol—SLCO1B3—Metabolism—HPGDS—testicular cancer	1.65e-05	0.00102	CbGpPWpGaD
Estradiol—Rash—Epirubicin—testicular cancer	1.65e-05	0.0002	CcSEcCtD
Estradiol—Dermatitis—Epirubicin—testicular cancer	1.65e-05	0.000199	CcSEcCtD
Estradiol—AOX1—Metabolism—STK11—testicular cancer	1.64e-05	0.00102	CbGpPWpGaD
Estradiol—Headache—Epirubicin—testicular cancer	1.64e-05	0.000198	CcSEcCtD
Estradiol—SLC22A3—Metabolism—HPGDS—testicular cancer	1.62e-05	0.001	CbGpPWpGaD
Estradiol—Dizziness—Doxorubicin—testicular cancer	1.6e-05	0.000194	CcSEcCtD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.56e-05	0.000967	CbGpPWpGaD
Estradiol—Nausea—Epirubicin—testicular cancer	1.55e-05	0.000188	CcSEcCtD
Estradiol—Vomiting—Doxorubicin—testicular cancer	1.54e-05	0.000186	CcSEcCtD
Estradiol—Rash—Doxorubicin—testicular cancer	1.53e-05	0.000185	CcSEcCtD
Estradiol—Dermatitis—Doxorubicin—testicular cancer	1.52e-05	0.000184	CcSEcCtD
Estradiol—Headache—Doxorubicin—testicular cancer	1.52e-05	0.000183	CcSEcCtD
Estradiol—Nausea—Doxorubicin—testicular cancer	1.44e-05	0.000174	CcSEcCtD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.43e-05	0.000887	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.42e-05	0.000882	CbGpPWpGaD
Estradiol—AOX1—Disease—FGFR3—testicular cancer	1.35e-05	0.000838	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—HPGDS—testicular cancer	1.3e-05	0.000804	CbGpPWpGaD
Estradiol—AR—Gene Expression—H2AFZ—testicular cancer	1.28e-05	0.000793	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.28e-05	0.000792	CbGpPWpGaD
Estradiol—AOX1—Disease—KIT—testicular cancer	1.24e-05	0.000769	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—HPGDS—testicular cancer	1.21e-05	0.00075	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—STK11—testicular cancer	1.2e-05	0.000743	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—STK11—testicular cancer	1.18e-05	0.00073	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.16e-05	0.000722	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—HPGDS—testicular cancer	1.13e-05	0.000699	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—HPGDS—testicular cancer	1.11e-05	0.000687	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—HPGDS—testicular cancer	1.03e-05	0.000636	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—HPGDS—testicular cancer	1.02e-05	0.000631	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—HPGDS—testicular cancer	1.02e-05	0.00063	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	9.94e-06	0.000617	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—H2AFZ—testicular cancer	9.85e-06	0.000611	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—HPGDS—testicular cancer	9.46e-06	0.000587	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—STK11—testicular cancer	9.41e-06	0.000584	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—STK11—testicular cancer	8.78e-06	0.000545	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—STK11—testicular cancer	8.19e-06	0.000508	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—STK11—testicular cancer	8.05e-06	0.000499	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—STK11—testicular cancer	7.45e-06	0.000462	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—STK11—testicular cancer	7.39e-06	0.000458	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—STK11—testicular cancer	7.38e-06	0.000458	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—HPGDS—testicular cancer	7.35e-06	0.000456	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—HPGDS—testicular cancer	6.94e-06	0.000431	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—STK11—testicular cancer	6.87e-06	0.000427	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—H2AFZ—testicular cancer	6.4e-06	0.000397	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—STK11—testicular cancer	6.37e-06	0.000395	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—HPGDS—testicular cancer	6.37e-06	0.000395	CbGpPWpGaD
Estradiol—ALB—Metabolism—HPGDS—testicular cancer	6.33e-06	0.000393	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KITLG—testicular cancer	5.89e-06	0.000366	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—HPGDS—testicular cancer	5.68e-06	0.000353	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—HPGDS—testicular cancer	5.55e-06	0.000344	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—STK11—testicular cancer	5.34e-06	0.000331	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—HPGDS—testicular cancer	5.18e-06	0.000321	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—STK11—testicular cancer	5.04e-06	0.000313	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—STK11—testicular cancer	4.62e-06	0.000287	CbGpPWpGaD
Estradiol—ALB—Metabolism—STK11—testicular cancer	4.6e-06	0.000285	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—HPGDS—testicular cancer	4.43e-06	0.000275	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—FGFR3—testicular cancer	4.38e-06	0.000272	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—STK11—testicular cancer	4.13e-06	0.000256	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—STK11—testicular cancer	4.03e-06	0.00025	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KIT—testicular cancer	4.02e-06	0.000249	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—STK11—testicular cancer	3.76e-06	0.000234	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—HPGDS—testicular cancer	3.42e-06	0.000212	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—STK11—testicular cancer	3.22e-06	0.0002	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—STK11—testicular cancer	2.48e-06	0.000154	CbGpPWpGaD
